May 02, 2013, 06.26 PM | Source: CNBC-TV18
Sudarshan Sukhani of s2analytics.com is of the view that one can buy Havells India.
Sudarshan Sukhani (more)
Technical Analyst, s2analytics.com | Capital Expertise: Equity - Technical
Sukhani told CNBC-TV18, "The market is up so today there is no need to go and experiment with a short position. We want to buy Havells India. It has moved out of a consolidation. It was already in an uptrend, so the breakout is a continuation of the existing uptrend. Any breakout has some momentum, may be by today 3.30 PM that momentum should give us some points on the long side."
He further added, " Aurobindo Pharma has made a very attractive bullish breakout, it is an ascending triangle. Such breakouts usually tell us that a significant up move is coming, so it is worthwhile getting in today as this move is just beginning to take shape."
Geojit BNP Paribas recommended hold rating on Have
Axis Direct has recommended hold rating on Havells
Geojit BNP Paribas has recommended hold rating on
Its net sales on standalone basis during the quart